Cargando…
Modeling the Effects of Vorinostat In Vivo Reveals both Transient and Delayed HIV Transcriptional Activation and Minimal Killing of Latently Infected Cells
Recent efforts to cure human immunodeficiency virus type-1 (HIV-1) infection have focused on developing latency reversing agents as a first step to eradicate the latent reservoir. The histone deacetylase inhibitor, vorinostat, has been shown to activate HIV RNA transcription in CD4+ T-cells and alte...
Autores principales: | Ke, Ruian, Lewin, Sharon R., Elliott, Julian H, Perelson, Alan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619772/ https://www.ncbi.nlm.nih.gov/pubmed/26496627 http://dx.doi.org/10.1371/journal.ppat.1005237 |
Ejemplares similares
-
In vivo kinetics of SARS-CoV-2 infection and its relationship with a person’s infectiousness
por: Ke, Ruian, et al.
Publicado: (2021) -
In vivo kinetics of SARS-CoV-2 infection and its relationship with a person’s infectiousness
por: Ke, Ruian, et al.
Publicado: (2021) -
In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication
por: Marsden, Matthew D., et al.
Publicado: (2017) -
Vorinostat—An Overview
por: Bubna, Aditya Kumar
Publicado: (2015) -
The synergic effect of vincristine and vorinostat in leukemia in vitro and in vivo
por: Chao, Min-Wu, et al.
Publicado: (2015)